Centlivre Mireille, Combadière Béhazine
Sorbonne Universités, UPMC University Paris 06, UMR_S CR7, Centre d'Immunologie et des Maladies Infectieuses- Paris, F-75013, Paris, France.
Centre d'Immunologie et des Maladies Infectieuses CIMI-Paris, 91 Boulevard de l'Hôpital, 75013, Paris, France.
BMC Immunol. 2015 Mar 26;16:18. doi: 10.1186/s12865-015-0075-2.
Vaccination has been a major advance for health care, allowing eradication or reduction of incidence and mortality of various infectious diseases. However, there are major pathogens, such as Human Immunodeficiency Virus (HIV) or the causative agent of malaria, for which classical vaccination approaches have failed, therefore requiring new vaccination strategies. The development of new vaccine strategies relies on the ability to identify the challenges posed by these pathogens. Understanding the pathogenesis and correlates of protection for these diseases, our ability to accurately direct immune responses and to vaccinate specific populations are such examples of these roadblocks. In this respect, the use of a robust, cost-effective and predictive animal model that recapitulates features of both human infection and vaccination is currently a much-needed tool. We discuss here the major limitations faced by modern vaccinology and notably, the development of humanized mice for assessing the immune system, along with their potential as vaccine models.
疫苗接种是医疗保健领域的一项重大进展,使各种传染病得以根除或发病率和死亡率降低。然而,存在一些主要病原体,如人类免疫缺陷病毒(HIV)或疟疾病原体,传统的疫苗接种方法对它们并不奏效,因此需要新的疫苗策略。新疫苗策略的开发依赖于识别这些病原体所带来挑战的能力。了解这些疾病的发病机制和保护相关性、我们准确引导免疫反应以及为特定人群接种疫苗的能力,都是这些障碍的例子。在这方面,使用一种强大、经济高效且具有预测性的动物模型来概括人类感染和疫苗接种的特征,目前是一种急需的工具。我们在此讨论现代疫苗学面临的主要局限性,尤其是用于评估免疫系统的人源化小鼠的开发及其作为疫苗模型的潜力。